Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Hope4Cancer® Institute Announces Expansion to Improve Patient Care and Treatment Offerings
  • USA - English


News provided by

Hope4Cancer® Institute

Aug 18, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Baja California, Mexico (PRWEB) August 18, 2015 -- The Hope4Cancer® Institute is pleased to announce that its 2015 clinic expansion and renovation project is now complete, offering a wide variety of new amenities, innovative treatments and an enhanced standard of care for all patients. The clinic now has 21 private in-patient rooms, more than double its previous capacity, with an extra bed for a companion in each room, Hope4Cancer®’s non-toxic protocols are based on the Seven Key Principles of Cancer Therapy™, a treatment philosophy outlined by its Founder and Medical Director, Dr. Antonio Jimenez, M.D., a world renowned figure in the arena on non-toxic cancer therapies.

To sustain its industry-leading doctor- and staff-to-patient ratios, Hope4Cancer® Institute has also doubled its staff of doctors, therapists, nurses, cooks and other support staff to sustain and improve its high standards of personalized care. The staff now includes a full time nutritionist, as well as several on-call consultants covering specializations such as surgical oncology, intensive care, internal medicine, biological dentistry, physical therapy, radiology, neurology, and others. Hope4Cancer remains at the forefront of clinical research and innovation, with the introduction of new selective anticancer and immune therapies such as Rigvir Virotherapy, PNC-27 and Irreversible Pepsin Fraction (IPF). Its treatment protocols are complemented with new devices and assessment technologies such as two new Pulsed Electromagnetic Field (PEMF) machines, Vitalscan and Cyberscan devices, Vibroacoustic therapy units, Ultraviolet Blood Irradiation units, a new hydraulic therapy table and more. Patients will be able to take advantage of the flexibility of several new therapy rooms as well as the convenience of an in-house pharmacy.

Hope4Cancer® has been professionally redesigned to provide patients and their families a positive, energizing and relaxing experience, synergizing their recovery. Many new indoor and outdoor common areas, such as a new sunken living room, encourage patients and their companions to congregate and interact with other fellow patients and staff. The “Garden of Hope”, a new indoor garden oasis features a fountain, soothing greenery and comfortable lounge chairs where patients can rest, relax, and meditate. Patients can, at any time, simply step outside to enjoy the Playas beach and boardwalk, but if they want to stay indoors, a sun deck with umbrella-equipped tables and teak recliners provides abundant sunshine and gentle ocean breeze. . Many clinic amenities are geared to provide patients with the most comfortable, healthful experience possible, including a juice bar, an herbal tea bar, an alkaline water hydration station, and more.

The current expansion was in response to growing worldwide interest in evidence-based, non-toxic alternative treatments for cancer patients. The Hope4Cancer® Institute is in a unique position to serve this need through its offerings of leading edge selective therapies in combination with time-tested natural treatments. Ty Bollinger, well known cancer advocate, author and founder of the Truth About Cancer organization, recently visited Hope4Cancer® Institute to interview Dr. Antonio Jimenez, his staff and patients with the objective of featuring the clinic to countless patients searching for a chance to overcome cancer. Last year, Dr. Jimenez was featured in the Truth About Cancer’s “Quest for the Cures … Continues” docu-series and will also be featured in the “Global Quest for the Cures” series, due to air in Fall 2015.

As more patients explore alternative and natural cancer treatments, the Hope4Cancer® Institute will continue to upgrade its protocols and amenities to ensure that they receive the highest quality and affordable treatment. For more information, please visit http://www.hope4cancer.com.

Company/Organization Info: The Hope4Cancer® Institute is located in Baja California, Mexico near the US/Mexico border. Founded by Dr. Antonio Jimenez, M.D. in 2000, the organization offers Rigvir® Virotherapy, Sono-Photo Dynamic Therapy, Bio-Immunotherapy, Hyperthermia and more. The Institute brings realistic hope to patients at all stages of cancer, including those who have been refused further treatment by conventional medicine practitioners.

Contact Information: For more information, please contact info(at)hope4cancer(dot)com or call 1-888-544-5993.

Hope4Cancer® Institute, Hope4Cancer® Institute, http://www.hope4cancer.com/, +1 888-932-4629 Ext: 117, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.